Lomakin, N. V., Bakirov, B. A., Protsenko, D. N., Mazurov, V. I., Musaev, G. H., Moiseeva, O. M., . . . Lutckii, A. A. (2021). The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: Results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study. Inflammation research, 70(10-12), 1233-1246. https://doi.org/10.1007/s00011-021-01507-5
Citácia podle Chicago (17th ed.)Lomakin, Nikita V., et al. "The Efficacy and Safety of Levilimab in Severely Ill COVID-19 Patients Not Requiring Mechanical Ventilation: Results of a Multicenter Randomized Double-blind Placebo-controlled Phase III CORONA Clinical Study." Inflammation Research 70, no. 10-12 (2021): 1233-1246. https://doi.org/10.1007/s00011-021-01507-5.
Citácia podľa MLA (8th ed.)Lomakin, Nikita V., et al. "The Efficacy and Safety of Levilimab in Severely Ill COVID-19 Patients Not Requiring Mechanical Ventilation: Results of a Multicenter Randomized Double-blind Placebo-controlled Phase III CORONA Clinical Study." Inflammation Research, vol. 70, no. 10-12, 2021, pp. 1233-1246, https://doi.org/10.1007/s00011-021-01507-5.